Moleculin Biotech (NASDAQ:MBRX) Coverage Initiated at StockN

StockNews.com assumed coverage on shares of Moleculin Biotech (NASDAQ:MBRX – Get Rating) in a research report report published on Sunday morning. The firm issued a sell rating on the stock. A number of other brokerages also recently issued reports on MBRX. Roth Mkm reiterated a buy rating and issued a $16.00 price target on shares […]

Related Keywords

Houston , Texas , United States , Roth Mkm , Walterv Klemp , Charles Schwab Investment Management Inc , Moleculin Biotech Inc , Renaissance Technologies , Moleculin Biotech , Get Rating , Schwab Investment Management , State Street Corp , Street Corp , Waldemar Priebe , Moleculin Biotech Daily , Nasdaq Mbrx , Ambrx , Medical , Initiated Coverage , Stocknews Com ,